Annual Bioprocessing of Advanced Cellular Therapies Congress

Dubai, UAE   December 03-04, 2018

Bioprocess 2018

Theme: Latest Innovations and Advancements in Cell & Gene Therapies to Alleviate Human Diseases

Bioprocess conference is delighted to welcome the participants from all over the world to attend the prestigious Annual Bioprocessing of Advanced Cellular Therapies Congress scheduled during December 03-04, 2018 in Dubai, UAE. The conference provides the global coliseum to international scholars and researchers to voice their research findings to the world. With representatives from all the major countries in attendance the atmosphere is exciting with open and friendly interaction between attendees. This is a conference, providing an opportunity for the bioprocess research’s and advanced cellular therapy industry to learn about current and upcoming issues, explore new developments in bioprocess technology, and interact with others with similar interests.

Session 1:  Cell Therapy

Cell therapy also known as cytotherapy .In this therapy cellular material is injected into a patient. It is based on the fact human cells could be used to prevent the human body rejecting transplanted organs, leading in time to successful transplantation of various body organs. In more recent work, cell encapsulation is done as a means to shield therapeutic cells from the host immune response. Recent work includes micro-encapsulating cells in a gel core surrounded by a solid, but permeable, shell. New types of treatment can be done with the help of stem cell therapy, some researcher believes. In mainstream medicine, cell therapy is supported by a distinct healthcare industry which sees strong prospects for future growth. The aim of organizing the Bioprocess conference is to supply exposure to technologies and international tie-ups and to supply data regarding recent trends in bioprocess.

Bioprocess Conference | Biotechnology Conference |Cell Therapy Conference | Cell Conference | Biotechnology Conference | Molecular Biology Conference | Genetic Engineering Conference | Bacteriology Conference

 Session 2: Stem Cell Therapy

 Stem cells are biological cells that can differentiate into different cells and has the ability to produce more of the same type of stem cells. Stem-cell therapy uses stem cells to treat or prevent a disease or condition. Various medical therapies use adult stem cells.  For e.g. (Transplantation of bone marrow). Stem cells are synthetically grown and can be used for transforming particular cell types with characteristics similar with cells of various tissues such as nerves or muscles. Embryonic cell lines and analogous embryonic stem cells generated through somatic cell nuclear transfer or dedifferentiation has also found useful. Bioprocess conference brings the researchers together to present and discuss their work.

Bioprocess Conference | Biotechnology Conference |Cell Therapy Conference | Cell Conference | Biotechnology Conference | Molecular Biology Conference | Genetic Engineering Conference | Bacteriology Conference

Session 3: Cancer cell

Cancer cells are cells that divide continuously, form solid tumors or flood the blood with abnormal cells. Cell division is a normal process and helps in building and repairing of cells. Two daughter cells are obtained from parent cell, and these daughter cells are used to build new tissue, or to replace cells that have died because of ageing or damage. When there is no longer a need for more daughter cells healthy cells stops division process, but cancer cells continue to produce cells. These can spread in other part of the body. In Bioprocess conference researchers exchange the information and their research experiences.

Bioprocess Conference | Biotechnology Conference |Cell Therapy Conference | Cell Conference | Biotechnology Conference | Molecular Biology Conference | Genetic Engineering Conference | Bacteriology Conference

Session 4: Gene therapy

 The therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease is known as gene therapy. Gene therapy gives a idea to fix the genetic problem at its source. Way to fix a genetic problem. The polymers used here start translating into proteins, getting involved with target gene expression, or possibly correct genetic mutations. Gene editing is a technique where alteration of human genome is done to treat genetic diseases, viral diseases and cancer. More recently, increased understanding of gene therapy has led to development of DNA editing. Bioprocess conference gives information about the rapid growth in biotechnology which made the sector important to the economy of many developing countries.

Bioprocess Conference | Biotechnology Conference |Cell Therapy Conference | Cell Conference | Biotechnology Conference | Molecular Biology Conference | Genetic Engineering Conference | Bacteriology Conference

Session 5: Cloning

Cloning is a process used to create duplicate of DNA fragments (molecular cloning), cells (cell cloning), or organisms (organism cloning). The main use of Cloning is to amplify DNA particles containing whole genes, but it can also be used to amplify any DNA sequence such as promoters, non-coding sequences and randomly fragmented DNA.  Biological experiments are taking place regarding cloning and one of practical work going on is the production of proteins. The prime motivation for this discipline is clearly derived from the enormous biodiversity and genetic life in our planet.

Bioprocess Conference | Biotechnology Conference |Cell Therapy Conference | Cell Conference | Biotechnology Conference | Molecular Biology Conference | Genetic Engineering Conference | Bacteriology Conference

Session 6:  Bioprocess

A bioprocess deals with thing which are living and under this specific process the use of complete living cells and their components like chloroplast, bacteria etc. are used to obtain desired products. Transportation of energy and mass is elemental to many biological and environmental processes; knowledge of how energy and mass can be transported through material Is required especially in food processing, thermal design of bio medical devices, pollution and global warming. This Bioprocess Conference describes the current progress in the development of a selection of new anti-inflammatory and anticancer agents, discusses some difficulties encountered during the development process and suggests how these difficulties may be overcome in the near future through applications of recent advances in biotechnology.

Bioprocess Conference | Biotechnology Conference |Cell Therapy Conference | Cell Conference | Biotechnology Conference | Molecular Biology Conference | Genetic Engineering Conference | Bacteriology Conference

Session 7:  Allotransplantation

 

 

 

 

Allotransplantation is the process of reallocating of an organ, tissue or other body part from one person to another For example, in kidney transplants, one person donates to another person as he /she can survive with one kidney also. Organs received in this process are called an allograft or homograft, if it is from different species it is called xenograft. Composite tissue allotransplantation is doing great in world market.

Bioprocess Conference | Biotechnology Conference |Cell Therapy Conference | Cell Conference | Biotechnology Conference | Molecular Biology Conference | Genetic Engineering Conference | Bacteriology Conference

Session 8: Adoptive cell therapy

Adoptive cell transfer (ACT) is the process of transferring cell into the patient. The cells can be derived from the patient or from another individual. The cells are most commonly derived from the immune system as it has improved immune functionality and characteristics. The adoptive transfer of analogous parametric blood mononuclear cells has been used experimentally to treat patients with advanced solid tumors, including melanoma lung cancer, breast cancer sarcoma.

Bioprocess Conference | Biotechnology Conference |Cell Therapy Conference | Cell Conference | Biotechnology Conference | Molecular Biology Conference | Genetic Engineering Conference | Bacteriology Conference

Session 9: Embryonic stem cell

These are the cells derived from identical inner mass cells of a human embryo. The special characteristics of these cells are that they can grow into more than 200 type’s cells. Embryonic stem cell gives a idea in the field of study of genetic disease, investigation of early human development. These are also helpful in the treatment of genetic disease. The aim of organizing the Bioprocess conference is to supply exposure to technologies and international tie-ups and to supply data regarding recent trends in Bioprocess and Biotechnology.

Bioprocess Conference | Biotechnology Conference |Cell Therapy Conference | Cell Conference | Biotechnology Conference | Molecular Biology Conference | Genetic Engineering Conference | Bacteriology Conference

Session 10: Cancer immunotherapy

Cancer immunotherapy also known as immune oncology. It uses the immune system to treat cancer. They use the fact that cancer cells can be detected by immune system with the help of tumor associated antigens (TAAS). Active immunotherapy prepares the immune system to attack tumor cells by targeting TAAS. According to a study, the global immune-oncology market is estimated to be more than US$ 75 billion in 2020.

Bioprocess Conference | Biotechnology Conference |Cell Therapy Conference | Cell Conference | Biotechnology Conference | Molecular Biology Conference | Genetic Engineering Conference | Bacteriology Conference

Market Research

Introduction:

Cell therapy is benefiting greatly by the move of bioprocess suppliers toward ready-to-use, sterile, single-use systems, but focused development effort specifically for cell therapy applications is greatly needed. The transition to scalable technologies for processing cells will be central to cell therapy success.

Bioprocess and Cell Therapy in America:

The Americas dominate the cell therapy market owing to the rise in awareness among people, and high healthcare expenditure. According to the Centers for Disease Control and Prevention, in 2015, the total health expenditure in the United States was reported to be USD 3.2 trillion and hospital care accounted for a share of 32.3%.

Bioprocess and Cell Therapy in Europe:

Europe holds the second position in cell therapy market. It is expected that the support provided by government bodies for research & development and improvement in reimbursement policies in healthcare will drive the market in Europe region.

Bioprocess and Cell Therapy in Asia Pacific:

The Asia Pacific is the fastest growing cell therapy market owing to the huge patient pool and developing healthcare technology. Healthcare expenditure is also improving in various Asia Pacific countries. According to the Australian Institute of Health and Welfare, in the years 2015 to 2016, the total health expenditure was USD 170.4 billion, which is 3.6% higher than the expenditure of 2014–15.

Bioprocess and Cell Therapy in Middle East:

The Middle East has the lowest market for cell therapy due to lack of technical knowledge and poor medical facilities. Less awareness among the people and low health care expenditure are also the reasons for lowest market.

 Global Bioprocess universities

  • University of Sheffield, UK
  • University of Warwick, UK
  • Swansea  University, UK
  • The State University of New York, USA
  • University Sains Malaysia ,Malaysia
  • McGill University, Canada
  • University of Illinois at Urban Champaign, USA
  • University Malaysia Perlis, Malaysia
  • University of Georgia, USA
  • New York University, USA

 

Global Bioprocess Societies and Associations

Europe:

  • German Resource Centre for Genome Research
  • European Association of Pharm Biotechnology
  • European Federation of Biotechnology
  • European Peptide Society
  • International Union of Toxicology
  • European federation of biotechnology
  • European molecular biology laboratory
  • The European Association for Bio industries

USA:

  • American Society of Gene Therapy
  • American Association for Cancer Research
  • Alliance for cellular signaling
  • American Society for Cell Biology
  • American Society of human genetics
  • World health organization
  • American Society of Human Genetics (ASHG)

Asia Pacific:

  • Australasian Proteomics Society
  • Australian biotechnology association
  • The human genome variation society
  • The international center for genetic engineering and biotechnology

References

http://www.insightpharmareports.com/Affiliated-Reports/Cell-Therapy-Market-Research-Report/
https://cellgenetherapy.conferenceseries.com/2018
https://www.whatuni.com/postgraduate-courses/search?subject=bioprocess-engineering
https://www.hotcoursesabroad.com/india/training-degrees/international/masters/bioprocess-engineering-courses/slevel/57

 

 

 

 

 

  • Cell Therapy
  • Cancer cell
  • Gene Therapy
  • Genetic Engineering.
  • Bioprocess
  • Allotransplantation
  • Adoptive Cell Therapy
  • Embryonic Stem Cell
  • Cancer Immunotherapy
  • Molecular biology
  • pharmacology
  • Stem Cell Therapy

6 Organizing Committee Members

8 Renowned Speakers

Sergey Suchkov

Sechenov University
Russia

Peter Blas

University College London
UK

Mamdouh Nassar

Cairo University
Egypt

Joel I Osorio

Regenerage Clinic
Mexico

Segundo Mesa Castillo

Psychiatric Hospital of Havana
Cuba

John Grigoriadis

Biogenea Pharmaceuticals Ltd
Greece

Nazanin Haghighat

Semnan University
Iran

Suruchi Garg

Aura Skin Institute
India

Media Partners & Collaborations

  • Media Partner

  • Media Partner

  • Media Partner

  • Media Partner